Ownership

Kanya Rajangam - Pres. & Chief Med. & Dev. Off. at Senti Biosciences, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Pres. & Chief Med. & Dev. Off.
Stock Symbol: SNTI on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Kanya Rajangam - trading volume in the past year for Senti Biosciences, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-1.48K	100%	$4.11	-$6.07K
Net	-1.48K	-100%		-$6.07K

Holdings reported by Kanya Rajangam for Senti Biosciences, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	87K	$196K	$2.25	Mar 10, 2025	Direct
Common Stock	33K	$74.3K	$2.25	Mar 10, 2025	Iyer Family Revocable Trust dated Aug 26 2012
Series A Convertible Preferred Stock	0	$0	$2,250.00	Mar 10, 2025	Iyer Family Revocable Trust dated Aug 26 2012	Common Stock
Stock Option (Right to Buy)	235K			Mar 6, 2025	Direct	Common Stock
Common Stock Warrant (right to buy)	49.5K			Dec 9, 2024	Iyer Family Revocable Trust dated Aug 26 2012	Common Stock

Transactions reported by Kanya Rajangam for Senti Biosciences, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.